Avoiding Data Leakage in Synthetic Data Projects
Synthetic data offers vast opportunities for machine learning model training without real-world constraints. Yet, beneath this promise lies the risk of…
Read more →Guardant Health’s GuardantINFORM platform combines de-identified longitudinal clinical and genomic data from more than 207,000 patients tested with its Guardant360 liquid-biopsy assay, used by biopharma for clinical-trial design and post-marketing research. Guardant Health is publicly traded (Nasdaq: GH).
Tabular